Patents by Inventor Daniel B. Carr

Daniel B. Carr has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FORMULATIONS OF LOW DOSE DICLOFENAC AND BETA-CYCLODEXTRIN
    Publication number: 20150105467
    Abstract: The present invention is directed to a pharmaceutical composition containing a unit dose of a diclofenac compound effective to induce analgesia; and a beta-cyclodextrin compound; wherein the dose of the diclofenac compound is less than 10 mg. The present invention is also directed to methods of treating a subject in need of analgesia with the pharmaceutical compositions of the invention.
    Type: Application
    Filed: December 19, 2014
    Publication date: April 16, 2015
    Applicant: JAVELIN PHARMACEUTICALS, INC.
    Inventors: Curtis Wright, Daniel B. Carr, Fred H. Mermelstein
  • Formulations of low dose diclofenac and beta-cyclodextrin
    Patent number: 8946292
    Abstract: The present invention is directed to a pharmaceutical composition containing a unit dose of a diclofenac compound effective to induce analgesia; and a beta-cyclodextrin compound; wherein the dose of the diclofenac compound is less than 75 mg, e.g., from about 18.75 mg to about 37.5 mg. The present invention is also directed to methods of treating a subject in need of analgesia with the pharmaceutical compositions of the invention.
    Type: Grant
    Filed: May 12, 2011
    Date of Patent: February 3, 2015
    Assignee: Javelin Pharmaceuticals, Inc.
    Inventors: Curtis Wright, Daniel B. Carr, Fred H. Mermelstein
  • METHODS OF TREATING PAIN
    Publication number: 20140221490
    Abstract: The presently disclosed subject matter is directed to methods of treating post-operative pain by administering a combination of a lower than minimum approved dose of diclofenac and beta-cyclodextrin. The presently disclosed subject matter is also directed to methods of treating pain in high risk or obese mammals in need of analgesia.
    Type: Application
    Filed: July 19, 2012
    Publication date: August 7, 2014
    Applicant: Hospira, Inc.
    Inventors: Peter Lacouture, Marcelo Garcia De Rocha, Daniel B. Carr
  • FORMULATIONS OF LOW DOSE DICLOFENAC AND BETA-CYCLODEXTRIN
    Publication number: 20140107209
    Abstract: The present invention is directed to a pharmaceutical composition containing a unit dose of a diclofenac compound effective to induce analgesia; and a beta-cyclodextrin compound; wherein the dose of the diclofenac compound is less than 10 mg. The present invention is also directed to methods of treating a subject in need of analgesia with the pharmaceutical compositions of the invention.
    Type: Application
    Filed: October 10, 2013
    Publication date: April 17, 2014
    Inventors: Curtis Wright, Daniel B. Carr, Fred H. Mermelstein
  • Formulations of low dose diclofenac and beta-cyclodextrin
    Patent number: 8580954
    Abstract: The present invention is directed to a pharmaceutical composition containing a unit dose of a diclofenac compound effective to induce analgesia; and a beta-cyclodextrin compound; wherein the dose of the diclofenac compound is less than 10 mg. The present invention is also directed to methods of treating a subject in need of analgesia with the pharmaceutical compositions of the invention.
    Type: Grant
    Filed: March 22, 2007
    Date of Patent: November 12, 2013
    Assignee: Hospira, Inc.
    Inventors: Curtis Wright, Daniel B. Carr, Fred H. Mermelstein
  • FORMULATIONS OF LOW DOSE DICLOFENAC AND BETA-CYCLODEXTRIN
    Publication number: 20110218247
    Abstract: The present invention is directed to a pharmaceutical composition containing a unit dose of a diclofenac compound effective to induce analgesia; and a beta-cyclodextrin compound; wherein the dose of the diclofenac compound is less than 10 mg. The present invention is also directed to methods of treating a subject in need of analgesia with the pharmaceutical compositions of the invention.
    Type: Application
    Filed: May 12, 2011
    Publication date: September 8, 2011
    Inventors: Curtis Wright, Daniel B. Carr, Fred H. Mermelstein
  • Antimicrobial compounds
    Patent number: 7723467
    Abstract: The invention features an antimicrobial composition comprising a substance P peptide and methods of inhibiting growth of a microorganism by contacting the microorganism with a substance P peptide. Bacterial and fungal pathogens are inhibited by the substance P compositions.
    Type: Grant
    Filed: July 13, 2005
    Date of Patent: May 25, 2010
    Assignee: New England Medical Center Hospitals, Inc.
    Inventors: Andrzej W. Lipkowski, Daniel B. Carr
  • Novel Chimeric Analgesic Peptides
    Publication number: 20090298755
    Abstract: The present invention provides a novel chimeric peptide containing an opioid peptide moiety and a nociceptive peptide moiety for producing analgesia.
    Type: Application
    Filed: March 28, 2007
    Publication date: December 3, 2009
    Inventors: Daniel B. Carr, Andrzej W. Lipkowski, Richard Kream, Aleksandra Misicka-Kesik
  • Formulations Of Low Dose Non-Steroidal Anti-Inflammatory Drugs And Beta-Cyclodextrin
    Publication number: 20070232567
    Abstract: The present invention is directed to pharmaceutical compositions containing (a) a dosage of a non-steroidal anti-inflammatory drug (NSAID) effective to induce analgesia an anti-inflammatory effect, or an anti-pyretic effect and (b) a beta-cyclodextrin compound; wherein the dosage of the NSAID compound is less than the minimum approved dose for the route of administration. Additionally, the present invention is directed to methods for treating a mammal in need of an analgesic, an anti-inflammatory, or an anti-pyretic agent comprising administering the pharmaceutical composition of the present invention.
    Type: Application
    Filed: March 22, 2007
    Publication date: October 4, 2007
    Inventors: Curtis Wright, Daniel B. Carr, Fred H. Mermelstein
  • Formulations Of Low Dose Diclofenac And Beta-Cyclodextrin
    Publication number: 20070232566
    Abstract: The present invention is directed to a pharmaceutical composition containing a unit dose of a diclofenac compound effective to induce analgesia; and a beta-cyclodextrin compound; wherein the dose of the diclofenac compound is less than 10 mg. The present invention is also directed to methods of treating a subject in need of analgesia with the pharmaceutical compositions of the invention.
    Type: Application
    Filed: March 22, 2007
    Publication date: October 4, 2007
    Inventors: Curtis Wright, Daniel B. Carr, Fred H. Mermelstein
  • Drug delivery composition
    Patent number: 6913760
    Abstract: The invention provides a drug delivery compositions and methods for treating pain. A drug delivery composition contains a polymer and at least two drugs sucha as an analgesic agent and an anesthetic agent.
    Type: Grant
    Filed: August 6, 2002
    Date of Patent: July 5, 2005
    Assignee: New England Medical Hospitals, Inc.
    Inventors: Daniel B. Carr, Andrzej W. Lipkowski, Donald L. Wise, Vasif Hasirci
  • Chimeric analgesic peptides
    Patent number: 6759520
    Abstract: The present invention provides a novel chimeric peptide containing an opioid peptide moiety and a nociceptive peptide moiety for producing analgesia.
    Type: Grant
    Filed: October 28, 1999
    Date of Patent: July 6, 2004
    Assignee: The New England Medical Center Hospitals, Inc.
    Inventors: Daniel B. Carr, Andrzej W. Lipkowski, Richard Kream, Aleksandra Misicka-Kesik
  • Drug delivery composition
    Publication number: 20030170288
    Abstract: The invention provides a drug delivery compositions and methods for treating pain. A drug delivery composition contains a polymer and at least two drugs sucha as an analgesic agent and an anesthetic agent.
    Type: Application
    Filed: August 6, 2002
    Publication date: September 11, 2003
    Inventors: Daniel B. Carr, Andrzej W. Lipkowski, Donald L. Wise, Vasif Hasirci
  • Novel antimicrobial compounds
    Publication number: 20030032599
    Abstract: The invention features an antimicrobial composition comprising a substance P peptide and methods of inhibiting growth of a microorganism by contacting the microorganism with a substance P peptide. Bacterial and fungal pathogens are inhibited by the substance P compositions.
    Type: Application
    Filed: November 20, 2001
    Publication date: February 13, 2003
    Inventors: Andrzej W. Lipkowski, Daniel B. Carr